Revolutionizing Oncology: A Critical Review of Artificial Intelligence and Stem Cells in Cancer Treatment

Cancer continues to be a leading cause of death globally, accounting for approximately 10 million fatalities in 2020 alone. Amid this public health crisis, innovations in oncology have heralded unprecedented advancements in patient care and therapeutic efficacy. Two such groundbreaking innovations are Artificial Intelligence (AI) and Stem Cell Research. This review critically examines the integration of AI technologies and stem cell therapies in revolutionizing the field of oncology. While AI algorithms have demonstrated the capability to improve early cancer detection rates by 20–30%, stem cell treatments show promise in elevating remission rates and potentially curing certain types of cancer. Despite these advantages, ethical considerations and data reliability pose challenges to widespread adoption. This paper synthesizes data from over 30 peer-reviewed articles, clinical studies, and medical reports to provide a comprehensive analysis of current practices, limitations, and future directions in the convergence of AI and stem cell technologies for cancer treatment.